Holen Sie sich die Stockscreener-App
77.32
1.50%
-1.18
Handel nachbörslich:
77.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$78.50
Offen:
$78.09
24-Stunden-Volumen:
1.78M
Relative Volume:
1.14
Marktkapitalisierung:
$37.69B
Einnahmen:
$10.40B
Nettoeinkommen (Verlust:
$980.00M
KGV:
39.15
EPS:
1.9749
Netto-Cashflow:
$1.61B
1W Leistung:
-4.93%
1M Leistung:
-2.37%
6M Leistung:
-1.24%
1J Leistung:
-10.93%
1-Tages-Spanne:
$76.73
$78.09
1-Wochen-Bereich:
$76.73
$82.52
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
77.32 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
41.46 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
ALC.SW Alcon Inc. (SIX) closes CHF62.56 on 11 Mar 2026: watch analyst targets - Meyka
RSI Check: Will Alcon Inc benefit from green energy policiesTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
UBS names Alcon top pick, sees strong catalyst path ahead - Investing.com
UBS reiterates Buy on Alcon stock, sees earnings beats ahead By Investing.com - Investing.com Australia
UBS reiterates Buy on Alcon stock, sees earnings beats ahead - Investing.com
Alcon Launches Hydrus Microstent in India to Advance Long-Term Glaucoma Management - eHealth Magazine
Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 - marketscreener.com
Stifel Raises Alcon (ALC) Price Target to $82, Maintains 'Hold' Rating | ALC Stock News - GuruFocus
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education - The Manila Times
What Analysts Are Saying About Alcon Stock - Benzinga
Stifel raises Alcon stock price target to $82 on sales growth - Investing.com Canada
Bernstein SocGen names Alcon stock top European medtech pick - Investing.com
Hedge Fund Bets: Can Alcon Inc outperform in the next rallyEarnings Miss & AI Enhanced Trading Alerts - baoquankhu1.vn
What analyst consensus implies for Alcon Inc. (2U3) stock2025 Pullback Review & Stock Portfolio Risk Control - Naître et grandir
Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound - marketscreener.com
Precision Trading with Alcon Inc. (ALC) Risk Zones - Stock Traders Daily
Alcon Earnings Report: Q4 Overview - Benzinga
Assessing Alcon (SWX:ALC) Valuation After Earnings Beat, Dividend Proposal And Intraocular Lens Momentum - simplywall.st
Alcon (SWX:ALC) Valuation Check After Earnings Strength And Analyst Optimism - Yahoo Finance
Systane eye drops: Are Alcon’s German bestsellers worth it in the US? - AD HOC NEWS
Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised - marketscreener.com
ALCAlcon Announces Amended Merger Agreement with STAAR Surgical - Revista ADVFN
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - mx.advfn.com
Alcon Inc. (ALC) Stock Analysis: Eyeing A 7.41% Upside In The Healthcare Sector - DirectorsTalk Interviews
An Inside Look at the Alcon-STAAR Surgical Deal Collapse - Medical Product Outsourcing
Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2 - GuruFocus
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alcon Surpasses 175 Million IOLs Implanted Globally - ChartMill
Alcon Stock After Earnings: Hidden Defensive Play for US Portfolios? - AD HOC NEWS
Alcon Eyes Cataract And Presbyopia Growth With LENSAR Deal And TOTAL30 - simplywall.st
Tariffs, Competition Ding Alcon’s Future - WFMZ.com
Equita SIM Upgrades Alcon to Buy, Raises PT - marketscreener.com
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC) - The Globe and Mail
Wells Fargo Upgrades Alcon (ALC) - Nasdaq
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday - Benzinga
2026 DallasCISO ORBIE Awards Recognize Top Security Executives - GlobeNewswire Inc.
Barclays Maintains Rating for Alcon (ALC) and Raises Price Targe - GuruFocus
Today's Analyst Upgrade for Alcon (ALC) with New Price Target | - GuruFocus
Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating - marketscreener.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk, U.S. Bancorp, and More - AOL.com
Wells Fargo upgrades Alcon stock rating on new product growth By Investing.com - Investing.com Nigeria
Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Alcon Inc. (NYSE:ALC) Q4 2025 Earnings Call Transcript - Insider Monkey
Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up - marketscreener.com
Wells Fargo upgrades Alcon stock rating on new product growth - Investing.com
ALC: Needham Maintains Buy Rating and Raises Price Target to $10 - GuruFocus
Alcon (ALC) Receives Upgrade as Growth Prospects Brighten - GuruFocus
Why Is Alcon Inc. (ALC) Stock Up Today? - Meyka
Lensar® provides update on pending acquisition by Alcon - marketscreener.com
Lensar® Provides Update On Pending Acquisition By Alcon - TradingView
LENSAR Updates Timeline for Pending Alcon Acquisition Review - TipRanks
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):